CWM
BMRN icon

Calamos Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Calamos Wealth Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,592
Closed -$349K – 281
2020
Q3 		$349K Sell
4,592
-76
-2% -$7.69K 0.04% 217
2020
Q2 		$576K Buy
+4,668
New +$464K 0.07% 164
2017
Q1 		– Sell
-14,625
Closed -$1.21M – 235
2016
Q4 		$1.21M Sell
14,625
-1,141
-7% -$98.1K 0.2% 139
2016
Q3 		$1.46M Buy
+15,766
New +$1.48M 0.25% 127

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return